University of Technology Sydney

96010 Integrated Therapeutics 2

6cp; 2hpw (supporting online activities e.g. Q&A, case discussion, online modules), 2 x 2hpw (workshop)
Requisite(s): (96006 Integrated Therapeutics 1 AND 96005 Professional Services 2 AND 96007 Drug Disposition AND (96008 Evidence-based Practice OR 96858 Evidenced-based Primary Health Care))
These requisites may not apply to students in certain courses.
There are course requisites for this subject. See access conditions.


Building on 96006 Integrated Therapeutics 1, this subject focuses on the optimal use of pharmacotherapy in the management of neurologic, endocrine, rheumatologic, ophthalmic, dermatologic and mental health disorders. The epidemiology, pathophysiology, diagnosis and clinical presentation of illness and disease are reviewed. Using an integrated approach, treatment and management options are considered with reference to relevant pharmacology, medicinal chemistry, formulation, pharmacokinetics and clinical properties of targeted therapies.

This subject contributes to the Master of Pharmacy by providing students with the knowledge and skills to optimise pharmacotherapy and clinical management of illness and disease.

Typical availability

Autumn session, City campus

Detailed subject description.

Access conditions

Note: The requisite information presented in this subject description covers only academic requisites. Full details of all enforced rules, covering both academic and admission requisites, are available at access conditions and My Student Admin.